Skip to content

EmbryoGlue as an Embryo Transfer Medium

A Randomised Controlled Trial Assessing the Effectiveness of EmbryoGlue® as an Embryo Transfer Medium in IVF Treatment Cycles

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03332680
Enrollment
730
Registered
2017-11-06
Start date
2017-06-16
Completion date
2019-11-30
Last updated
2018-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

In Vitro Fertilisation (IVF) is an increasingly common treatment for infertility. Clinics which offer IVF are continuously trying to improve their success rates, measured by the numbers of IVF cycles which result in the birth of a live baby. One factor which is thought to have contributed to the success of IVF is the improvements in the embryo culture media, that is, the fluid in which the embryo resides in the laboratory before being replaced into a woman's womb. This trial seeks to identify if IVF cycles in which a particular culture media called EmbryoGlue is used have better results when compared to IVF cycles in which a conventional embryo transfer media is used.

Interventions

BIOLOGICALEmbryoGlue® (laboratory culture medium)

Embryos placed in this medium prior to transfer

BIOLOGICALStandard control medium

Embryos placed in this medium prior to transfer

Sponsors

Oxford Fertility Limited, United Kingdom
CollaboratorUNKNOWN
University of Oxford
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

In terms of blinding, the physician and/or nurses as well as the patients will be blinded and will not know what arm of the study the participant has been allocated too. The embryologists however will be unblinded (as they provide intervention and will have to be aware).

Intervention model description

This study is a positive control study with a single site two arm parallel design

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

• Couples having embryo transfer for fertility treatment

Exclusion criteria

* Cycles in which elective freezing of all embryos is clinically indicated (e.g. severe risk of OHSS, biopsy patients) * Use of donor gametes * Having endometrial scratch technique this cycle * Concurrent participation in clinical trial(s) * Previously randomised to this study * Planned self-fund of EmbryoGlue as transfer media

Design outcomes

Primary

MeasureTime frame
Live Birth Rateoutcome data up to 9 months after intervention

Secondary

MeasureTime frame
Implantation rateoutcome data up to 9 months after intervention
Clinical pregnancy rates,outcome data up to 9 months after intervention
Adverse IVF events.outcome data up to 9 months after intervention

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026